Work

Efficacy of Bevacizumab plus Erlotinib for Advanced Hepatocellular Carcinoma and Predictors of Outcome: Final Results of a Phase II Trial

Year: 2012

Type: article

Study design: Clinical Trial

Source: Oncology

DOI: 10.1159/000335963

Authors: A.O. Kaseb, E. Garrett-Mayer, J.S. Morris, L. Xiao, E. Lin, G. Onicescu, M.M. Hassan, H.M. Hassabo, M. Iwasaki, F.L. Deaton, J.L. Abbruzzese, M.B. Thomas

Institutions: The University of Texas MD Anderson Cancer Center, Medical University of South Carolina, MUSC Hollings Cancer Center

Language: English

Topic: Hepatocellular Carcinoma Treatment and Prognosis

Subfield: Hepatology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2020531037

FWCI: 8.381

Cites: 28

Cited by: 87

Related to: 10